Clinical Trials Logo

Bruxism, Sleep clinical trials

View clinical trials related to Bruxism, Sleep.

Filter by:
  • None
  • Page 1

NCT ID: NCT04842136 Completed - Headache Clinical Trials

Factors Affecting Patients With Myofascial Temporomandibular Disorders

Start date: January 13, 2020
Phase:
Study type: Observational

The aim of the study was to assess and compare the relationship between jaw function, neck disability, sleep quality, fatigue, and headache in patients with myofascial Temporomandibular Disorder (TMD) with Sleep Bruxism (SB) and without (non-SB).

NCT ID: NCT03833505 Completed - Bruxism, Sleep Clinical Trials

Enterobius Vermicularis and Bruxism in Children

Start date: March 15, 2017
Phase:
Study type: Observational

Background. Bruxism is an involuntary, non-functional activity of the masticatory system, and is frequently seen in childhood. Bruxism has many aetiologies, like malocclusion, psychological factors, allergies and gastrointestinal disorders. Aim. To investigate the relationship between Enterobius vermicularis infection and bruxism in children.

NCT ID: NCT03810248 Completed - Clinical trials for Obstructive Sleep Apnea

Association Between Obstructive Sleep Apnea and Bruxism

Start date: July 17, 2019
Phase:
Study type: Observational

The objective of this retrospective observational study will be to investigate the between the Obstructive Sleep Apnea Syndrome (OSAS) and Sleep Bruxism (SB), in individuals diagnosed through polysomnography (PSG).

NCT ID: NCT03749928 Withdrawn - Bruxism, Sleep Clinical Trials

OstiSense Biosensor in Bruxism Reduction - A Clinical Study

Start date: December 2021
Phase: N/A
Study type: Interventional

The overall objective of the clinical studies with the OstiSense biosensor tool will be to evaluate whether the use of the OstiSense biosensor tool significantly reduces the number of sleep bruxism events per night as well as the duration of those events for patients with bruxism.The product under investigation is the OstiSense biosensor with biofeedback for bruxism therapy. The sensor is integrated in a night-guard like device and registers the pressure created during a bruxism episode. If a predetermined pressure threshold is exceeded, the integrated vibration tool will be activated, and the vibrations will/should remind the wearer to stop clenching his jaws and relax his facial muscles. Due to this feedback, the number of bruxism episodes as well as clenching time per episode should be reduced. The sensor also identifies the time of grinding and the sleep stage of the patient.

NCT ID: NCT03710174 Recruiting - Bruxism, Sleep Clinical Trials

Evaluation of the Effectiveness of Infrared LED Photobiomodulation in Children With Sleep Bruxism

Start date: August 1, 2017
Phase: Phase 2
Study type: Interventional

Sleep bruxism is a masticatory muscle activity characterized as rhythmic (phasic) or non‐rhythmic (tonic). The literature reports the prevalence rates, diverse etiologies and different types of treatment. In children and adolescents, etiological factors, such as breathing pattern and sleep quality, have recently been addressed in studies investigating sleep bruxism. While studies have also reported psychological factors as a causal factor, this aspect requires further research. There are also divergences in opinion regarding the form of treatment. New therapies for adults, such as botulinum toxin, have been investigated, but such techniques are not applicable for individuals in the growth and development phase. Thus, photobiomodulation therapy has piqued the interest of researchers, as this noninvasive method has demonstrated positive results in problems related to muscle tissues. This document describes the protocol for a proposed study to evaluate morphological and psychosocial aspects in children and adolescents with awake bruxism and their responses to photobiomodulation therapy with infrared LED.